ZeroStack Corp. (ZSTK)
ZeroStack Corp. (ZSTK) Stock Price, Analysis & Data
| Bid | 3.35 |
| Market Cap | 20.88M |
| Revenue (ttm) | 40.03M |
| Net Income (ttm) | -174.8M |
| Beta | 1.71 |
| EPS (ttm) | -44.52 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | 0.03 |
| P/S (ttm) | 0.52 |
| Earnings Date | n/a |
| Ask | 1.5 |
| Volume | 4,458 |
| Avg. Volume (20D) | 20,156 |
| Open | 1.99 |
| Previous Close | 1.69 |
| Day's Range | 1.73 - 1.99 |
| 52-Week Range | 1.32 - 47.00 |
| Analyst | n/a |
| Price Target | 11 (507.73%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ZSTK
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates...
Financial Performance
In 2025, ZeroStack's revenue was 35.68M, a decrease of -0.53% compared to the previous year's 35.87M. Earnings were -119.73M, an increase of 652.7%.
Financial StatementsAnalyst Forecast
According to 1 analyst ratings, the average rating for ZSTK stock is "null". The 12-month stock price forecast is 11, which is upside of 507.73% from the latest price.
Stock Forecasts
